Researchers have developed a new way to craft custom synthetic vascular grafts for patients in need of immediate care. The technique has shown early potential to be a game-changer for cardiovascular care. 

The newly cleared pVasc NET includes a dual-layer filter not available on the company's previous devices. 

After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.

Vexev, an Australian medtech company, wants to improve patient access to high-quality vascular imaging. The company has now raised a total of $19 million.

Healthcare providers should return any unused devices to the manufacturer. 

The deal, first announced in April, includes an upfront payment of $20 million and up to an additional $25 million based on certain milestones.

Customers should return these devices to the manufacturer due to a risk of the tip separating during use. 

PAD patients treated with GLP-1 receptor agonists lived longer, stayed out of the hospital more and experienced fewer amputations than those given metformin.

More than 50,000 devices are being recalled due to pinhole leaks associated with multiple risks. Customers should return any unused cannulae to Medtronic.

A Florida resident, 55, nearly died from a pulmonary embolism in 2025. A new lawsuit claims he would have gone to the hospital much sooner if not for a chatbot's guidance.